Scarica l'app Stockscreener
1.26
2.44%
0.03
Dopo l'orario di chiusura:
1.28
0.02
+1.59%
Precedente Chiudi:
$1.23
Aprire:
$1.27
Volume 24 ore:
1.51M
Relative Volume:
2.03
Capitalizzazione di mercato:
$3.06M
Reddito:
$212.10K
Utile/perdita netta:
$-40.19M
Rapporto P/E:
-0.000237
EPS:
-5313.2836
Flusso di cassa netto:
$-13.92M
1 W Prestazione:
+4.13%
1M Prestazione:
-5.26%
6M Prestazione:
-95.70%
1 anno Prestazione:
-99.99%
Intervallo 1D:
$1.23
$1.31
Intervallo di 1 settimana:
$1.16
$1.31
Portata 52W:
$1.05
$21,400.00
Aditxt Inc Stock (ADTX) Company Profile
Nome
Aditxt Inc
Settore
Industria
Telefono
909-488-0844
Indirizzo
737 N. FIFTH STREET, SUITE 200, RICHMOND
Confronta ADTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
1.26 | 2.99M | 212.10K | -40.19M | -13.92M | -5,313.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Aditxt Inc Borsa (ADTX) Ultime notizie
Aditxt CEO Highlights Immunotherapy at Investor Event - TipRanks
What drives Aditxt Inc. stock pricePowerful profit generation - jammulinksnews.com
What analysts say about Aditxt Inc. stockExplosive capital gains - Autocar Professional
Is Aditxt Inc. a good long term investmentSuperior risk-adjusted returns - jammulinksnews.com
Aditxt Inc. Stock Analysis and ForecastRapidly expanding wealth - jammulinksnews.com
Aditxt to Present at Wall Street Reporter’s Next Super Stock Livestream Today July 22, 2025, at 1 p.m. ET - Business Wire
Aditxt Showcases Pearsanta’s Diagnostic Advancements - TipRanks
Phexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy - MarketScreener
Phexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy - Benzinga
Aditxt CEO Discusses Strategic Initiatives at Livestream - MSN
Aditxt unveils bitcoin-backed strategy to support biotech ventures - Investing.com Australia
Aditxt launches Bitcoin treasury strategy to fund biotech ventures - Investing.com Australia
Aditxt launches Bitcoin treasury strategy to fund biotech ventures By Investing.com - Investing.com South Africa
Aditxt, Inc. Unveils bitXbio - MarketScreener
Aditxt unveils bitcoin-backed strategy to support biotech ventures By Investing.com - Investing.com South Africa
Aditxt Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization - The Globe and Mail
Evofem Biosciences Enters Securities Purchase Agreement - TipRanks
Aditxt CEO Discusses Strategic Growth at Livestream Event - The Globe and Mail
Adtx - AInvest
Aditxt to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today June 26, 2025, at 1 p.m. ET - Bluefield Daily Telegraph
Appili Therapeutics: Navigating Biodefense Challenges Amid Strategic Shifts - AInvest
Aditxt Inc. Integrates Bitcoin into Treasury Strategy with 302 Mentions in SEC Filing - AInvest
Aditxt Incorporates Bitcoin Focused Digital Asset Strategy - AInvest
Evofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board - citybiz
Aditxt Inc. Strengthens Board with Appointment of Evofem CEO Saundra Pelletier - citybuzz -
Aditxt names Evofem CEO to its board, eyes women’s health market By Investing.com - Investing.com South Africa
Aditxt names Evofem CEO to its board, eyes women’s health market - Investing.com India
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board Of Directors - MarketScreener
Aditxt (ADTX) Welcomes Saundra Pelletier to Its Board | ADTX Stock News - GuruFocus
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors | ADTX Stock News - GuruFocus
Evofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board of Directors - Business Wire
Saundra Pelletier, Evofem Biosciences' CEO, Dr. Friedrich Kapp, - GuruFocus
Saundra Pelletier, Evofem Biosciences' CEO, Dr. Friedrich Kapp, Co-CEO Of Adimune, And Chris Mitton, President Of Pearsanta, Will Join Aditxt Weekly Update On June 6 - MarketScreener
Aditxt Inc Azioni (ADTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):